BBLG
Bone Biologics Corporation
NASDAQ · Healthcare · Medical - Devices · US
$0.57
+1.86%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expense | 895.4K | 1.1M | 2.1M | 6.9M | 1.6M |
| SG&A Expense | 2.2M | 2.2M | 2.1M | 2.5M | 2.1M |
| General & Admin Expense | 2.2M | 2.2M | 2.1M | 2.5M | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 3.1M | 3.2M | 4.2M | 9.4M | 3.7M |
| Cost and Expenses | 3.1M | 3.2M | 4.2M | 9.4M | 3.7M |
| Operating Income (EBIT) | (3.1M) | (3.2M) | (4.2M) | (9.4M) | (3.7M) |
| Non-Operating | |||||
| Interest Income | 168.6K | 122.0K | 55.7K | 1.9K | — |
| Interest Expense | — | — | — | — | 731.7K |
| Net Interest Income | 168.6K | 122.0K | 55.7K | 1.9K | (731.7K) |
| Other Non-Op Income/Expense | 170.5K | 126.0K | 106.7K | 479.6K | 2.2M |
| Non-Operating Income (excl Interest) | (178.0K) | (126.0K) | (107.0K) | (479.6K) | (2.9M) |
| EBT (Pre-Tax Income) | (2.9M) | (3.1M) | (4.1M) | (8.9M) | (1.5M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (2.9M) | (3.1M) | (4.1M) | (8.9M) | (1.5M) |
| Earnings from Cont. Ops | (2.9M) | (3.1M) | (4.1M) | (8.9M) | (1.5M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (2.9M) | (3.1M) | (7.3M) | (8.9M) | (1.5M) |
| Per Share | |||||
| Basic EPS | ($1.86) | ($2.65) | ($4.83) | ($34.01) | ($31.15) |
| Diluted EPS | ($1.86) | ($2.65) | ($4.83) | ($34.01) | ($31.20) |
| Revenue Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 1.8M | 1.2M | 1.5M | 263137 | 47596 |
| Diluted Shares Outstanding | 1.8M | 1.2M | 1.5M | 263137 | 47658 |
| Profitability Metrics | |||||
| EBITDA | (2.2M) | (3.1M) | 107.2K | 479.6K | (752.9K) |
| D&A | 715.3K | — | 4.2M | 9.4M | — |
| EBIT | (2.9M) | (3.1M) | (4.1M) | (8.9M) | (752.9K) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026